Beijing, China

Zhehui Peng


 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: The Innovative Work of Zhehui Peng in Recombinant Protein Development

Introduction: Zhehui Peng is an accomplished inventor based in Beijing, China, known for his significant contributions to the field of biotechnology. With a focus on recombinant fusion proteins, his work has promising implications for vaccine development and antibody preparation.

Latest Patents: Peng holds a patent for a "Method for preparing bacterial polysaccharide-modified recombinant fusion protein and use of the protein." This groundbreaking invention outlines a method that involves co-expressing a recombinant fusion protein with the O-oligosaccharyltransferase PglL within an O-antigen ligase gene-defective bacterium. This innovative approach allows for the linking of polysaccharides, whether endogenous or exogenous to the bacterium, to the recombinant fusion protein, leading to the creation of a bacterial polysaccharide-modified recombinant fusion protein. The resultant protein has significant applications in preparing antibodies against bacterial polysaccharides and in the development of vaccines.

Career Highlights: Zhehui Peng is currently affiliated with the Institute of Biotechnology at the Academy of Military Medical Sciences in China. His dedication to research in biotechnology has led to advancements that enhance the understanding and application of recombinant proteins in medical science.

Collaborations: Throughout his career, Zhehui Peng has collaborated with notable colleagues such as Jun Wu and Chao Pan. Together, their collective expertise has contributed to the successful progression of various research projects and innovations.

Conclusion: Zhehui Peng exemplifies the spirit of innovation in the biomedical field. His patented method for preparing modified recombinant fusion proteins represents a significant step forward in the development of new medical therapies, particularly in the realm of vaccines and antibody production. As he continues his work at the Institute of Biotechnology, his contributions are expected to have a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…